Revelstoke Capital Partners
Revelstoke Capital Partners is a healthcare-focused private equity firm investing in healthcare services, healthcare technology, and health and wellness companies.
- Healthcare and life sciences private equity investment firm
- Healthcare & Life Sciences PEF
- Tier III
Overview
Revelstoke Capital Partners is a healthcare-focused private equity firm investing in healthcare services, healthcare technology, and health and wellness companies.
The firm targets businesses that can scale through organic development, operating improvement, and add-on acquisitions. Its portfolio reflects opportunities in fragmented healthcare markets where stronger systems, management resources, and geographic expansion can create more durable organizations. Within The Economy Wiki, the firm is connected to the Healthcare & Life Sciences PEF market category.
Firm facts
| Institution | Revelstoke Capital Partners |
| Type | Healthcare and life sciences private equity investment firm |
| Headquarters | Denver, United States |
| Founded | 2013 |
| Primary ranking focus | Healthcare & Life Sciences PEF |
| Highest 2026 tier | Tier III |
Activities and investment capabilities
Revelstoke’s model is particularly relevant to services and technology-enabled platforms addressing access, efficiency, and specialized care delivery. These investments require careful integration and attention to quality as organizations increase in size.
Healthcare investing
Equity investment across healthcare services, products and technology.
Life sciences exposure
Capital for pharmaceutical, biotechnology, medtech and outsourced-service platforms.
Sector value creation
Support informed by regulation, reimbursement, clinical workflows and market access.
Strategy and transaction coverage
Strategy and sector coverage
Healthcare services; life sciences; pharmaceuticals; medtech; diagnostics; healthcare IT
Transaction and ownership contexts
Buyouts; growth investments; recapitalizations; platform formation; add-on acquisitions
Market position
Revelstoke Capital Partners fits Tier III because it is an active specialist with a clear healthcare mandate and visible platform-building experience, while remaining younger and more concentrated than the established firms in Tier II.
Revelstoke Capital Partners is assessed within the Healthcare & Life Sciences PEF framework. For wider market context, see The Mid-Market Advantage in Healthcare Private Equity.
Competitive context
Revelstoke Capital Partners is recognized Tier III in Top 30 Healthcare & Life Sciences PEF 2026. The ranking compares firms by institutional relevance, specialist capability, investment activity, operating depth and market positioning. Comparable-firm links below support navigation and do not imply that every institution competes for every transaction or asset.
Leadership and governance
Leadership, investment-committee composition and operating resources may change over time. Current information should be confirmed through Revelstoke Capital Partners’s official website.
| Leadership area | Current source |
|---|---|
| Investment and operating leadership | Current team and governance information |
Corporate and public information
This profile refers to Revelstoke Capital Partners as the public-facing investment organization. Individual funds, management companies, advisers and regulated entities may use separate legal names across jurisdictions.
Corporate and disclosure information
| Organization | Revelstoke Capital Partners |
| Headquarters | Denver, United States |
| Public website | revelstokecapital.com |
| Profile basis | Public institutional information and Capital Ranking editorial research |
Ranking recognition
Related Economy analysis
Selected Economy Markets articles provide context for the investment, diligence, financing and value-creation themes relevant to this firm:
- The Mid-Market Advantage in Healthcare Private Equity
- Middle-Market Private Equity: Returns, Scale and Manager Selection
- Private Equity Technology Due Diligence in the AI Era
